highperformr logo

ARTIDIS's Overview

Total employees75
HeadquartersBasel
Founded2018

Artidis AG is a clinical-stage health technology company founded as a spin-off from the Biozentrum and the Swiss Nanoscience Institute at the University of Basel. The company is developing a pioneering nanomechanical biomarker platform for cancer diagnosis and personalized treatment. Their ARTIDIS® technology, based on Atomic Force Microscopy (AFM), measures the physical properties of cells and tissues at the nanoscale. This allows for rapid and precise identification of cancer, assessment of its aggressiveness, and prediction of therapy response, aiming to empower clinicians with data-driven insights for better patient outcomes.

Where is ARTIDIS's Headquarters?

HQ Function

The Basel headquarters serves as the central hub for Artidis's research and development, clinical operations, corporate strategy, and global business management.

Notable Features:

Located within Technopark Basel, providing access to a network of innovative companies, research institutions, and modern laboratory facilities. Its proximity to the University of Basel and major pharma companies fosters collaboration.

Work Culture:

Artidis likely fosters a highly innovative, science-driven, and collaborative work environment. The culture emphasizes precision, cutting-edge research, and a strong focus on translating scientific breakthroughs into clinical applications to impact patient lives.

HQ Significance:

The headquarters' location in Basel is strategically important, leveraging Switzerland's world-class biotech ecosystem, access to talent, research collaborations, and a supportive regulatory environment for medical devices and diagnostics.

Values Reflected in HQ: The headquarters' focus on advanced research and development within a collaborative ecosystem reflects Artidis's core values of innovation, scientific excellence, and patient-centricity.

Location:

Artidis, while headquartered in Switzerland, operates with a global outlook. Its primary functions supported globally include collaborative research partnerships with international institutions, conducting multi-center clinical trials across different countries (e.g., pivotal studies in Europe), and engaging in business development activities to prepare for market entry in key regions such as Europe and North America. The ARTIDISnet platform is designed for potential global deployment in clinical settings.

Street Address:

Technopark Basel, Hochbergerstrasse 60C

City:

Basel

State/Province:

Basel-Stadt

Country:

Switzerland

ARTIDIS's Global Presence

Cambridge, MA, USA

Address: One Broadway, 14th Floor, Cambridge, MA 02142 (Representative office/shared space example)

To facilitate engagement with the US Food and Drug Administration (FDA), connect with US-based research institutions and key opinion leaders, and expand Artidis's commercial footprint in the significant US healthcare market.

Buying Intent Signals for ARTIDIS

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Executive Team of ARTIDIS

As of April 2025, ARTIDIS' leadership includes:

Dr. Marija Plodinec - Co-Founder & Chief Executive Officer
Dr. habil. Martin Stolz - Chief Business Officer
Dr. med. Sven Wellmann - Chief Medical Officer
Markus Gstöttner - Chief Financial Officer
Dr. Gregor Dernick - Chief Technology Officer

Investors of ARTIDIS

ARTIDIS has been backed by several prominent investors over the years, including:

Bernina BioInvest
Hightech Gründerfonds (HTGF)
BioMedPartners
Redalpine
Verve Ventures
Several private investors and family offices

Executive New Hires/Exits in the Last 12 Months

Hire1
Exits0

Artidis has been strengthening its executive team to support its growth phase, particularly focusing on clinical development, business development, and preparing for commercialization. No major unexpected departures have been publicly noted, indicating team stability.

New Appointments:

Dr. med. Sven Wellmann, Dr. Sven Wellmann appointed as Chief Medical Officer to oversee clinical development and medical affairs, strengthening the company's clinical leadership.

Technology (Tech Stack) used by ARTIDIS

Discover the tools ARTIDIS uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

ARTIDIS Email Formats and Examples

Artidis AG likely uses standard corporate email formats. Common patterns include [first_initial][last]@[companydomain.com] or [first].[last]@[companydomain.com]. Based on publicly available information and common practices for Swiss tech companies, these are the most probable formats.

[first].[last]@artidis.com or [f][last]@artidis.com

Format

marija.plodinec@artidis.com

Example

80%

Success rate

News and media

PR NewswireFebruary 28, 2024

Artidis Completes Patient Recruitment for the ACD-BREAST Pivotal Clinical Study

Artidis announced the successful completion of patient recruitment for its ACD-BREAST pivotal clinical study. This marks a significant step in validating its nanomechanical biomarker technology for breast cancer diagnosis and therapy optimization, aiming to bring this innovation to patients....more

Artidis NewsFebruary 13, 2024

Artidis Appoints Dr. med. Sven Wellmann as Chief Medical Officer

Artidis has strengthened its leadership team with the appointment of Dr. med. Sven Wellmann as Chief Medical Officer. Dr. Wellmann, a renowned expert in neonatology and pediatric oncology, will lead Artidis' clinical development and medical affairs....more

Artidis News / European Journal of CancerOctober 26, 2023

Artidis Technology for Early Detection of Therapy Resistance Published in the European Journal of Cancer

A study published in the European Journal of Cancer demonstrated the potential of Artidis's nanomechanical biomarkers to detect therapy resistance in breast cancer patient-derived organoids early on. This could enable timely adjustments to treatment strategies....more

Highperformr’s free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including ARTIDIS, are just a search away.